Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Gene Expression Monitoring of Renal Allograft Status (GEM Tissue)

Clinical Trial Details

The purpose of this study is to learn more about a patient’s transplant and related complications. We will develop tests for assessing the status of the kidney transplant, as well as any potential complications. The study will help u to come up with ways to anticipate, diagnose and prognosticate problems associated with kidney transplants. The tissue collected in this study will be stored in a repository (database) to analyze for the presence of various markers believed to be involved in allograft dysfunction.

Key eligibility:

  • Awaiting or have undergone kidney transplant
  • Age greater than 7 years and less than 90 years
  • Ability to provide informed consent
  • Detailed eligibility provided when you contact the study team

Study contact by location

Upper East Side - Manhattan


Emmanuel Edusei
(212) 746-6112

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:



Open to Enrollment